top of page

Management

Gaines.Panel.4good.WEB.jpg

Weaver Gaines

Co-Founder, Chairman and CEO

Weaver Gaines has over 40 years of entrepreneurial, management, and legal experience, including over 25 years as a founder, fund-raiser, and manager of start-up life science companies. Most recently, he was a co-founder and CEO of OBMedical Company, a medical device company that developed and received FDA clearance for an electronic maternal fetal monitor, which was acquired by Philips Healthcare in 2018.

From 2008 to 2017, Gaines was Chairman of the Board of Nanotherapeutics, Inc. (now Ology Bioservices, Inc.), a specialty pharma company and manufacturer of a bone extender cleared by the FDA. Prior that that, Gaines founded Ixion  Biotechnology, a Florida-based, clinical-stage biotechnology company that developed stem cell and probiotic therapies focused on treatment of metabolic disorders. Ixion’s probiotic technology was acquired by QMed AB in 2007.

Gaines received a BA from Dartmouth College and a JD from the University of Virginia School of Law and was an Infantry officer who served in Vietnam from 1969-70, with a final rank of Captain.

Rick Giancola Headshot 2023.jpg

Rick Giancola

President

With over 35 years of experience in the life sciences industry, Mr. Giancola brings a wealth of knowledge and a proven track record of business development and strategic growth success to this role. He is passionate about neuromodulation technology and its powerful ability to transform lives.

 

As Owner and Managing Director of Otomed Consulting, LLC, Mr. Giancola has advised global leaders, emerging companies, venture capital and investment firms in the life sciences space on business development and operational systems of neuromodulation devices, including novel tinnitus treatments, hearing implants and innovative approaches for other neurological disorders. 

 

At Cochlear Americas, his team built the Latin American business, growing revenue by 30% year-over-year and establishing Latin America as a key component of Cochlear’s global strategy. He then joined Neuromonics, Inc. as CEO (later acquired by SoundVida) and bone conduction hearing pioneer Sophono (acquired by Medtronic). As Executive Vice President of the Americas/EMEA at Nurotron Biotechnology, Inc., Mr. Giancola drove significant growth by heading all commercial, clinical, research, regulatory, education and training activities for the Americas, Europe, the Middle East and Africa. His strategic initiatives resulted in a fivefold increase in sales in Latin America and EMEA in these diverse global markets.

 

Mr. Giancola holds an MBA from Syracuse University and a BA from Hobart College. Outside of work, he enjoys cycling, skiing, golfing and lacrosse. His commitment to professional and community involvement is evident through his roles on various boards and committees.

neil headshot.jpg

Neil Euliano

Chief Technology Officer

Neil Euliano has spent the past 20 years leading teams developing medical devices and technology. He is the chief designer and manager of the FDA cleared Philips Healthcare VentAssist team that developed intelligent decision support software for ventilated patients. He holds over 40 U.S. patents and has ten more pending. In addition, he has a long history in managing multi-disciplinary medical development teams and 19 years of experience managing R&D grants, including over $12M in industry and government funded research.

 

His commercialization and entrepreneurial experience includes being the cofounder of two companies, both of which led to FDA clearance, commercial sales, and acquisition. He served as Chairman of the Board and CTO of OBMedical during their acquisition by Philips Healthcare. He has been involved in the successful FDA clearance of more than 6 medical devices. Euliano is currently a Senior Science Advisor to etectRX, a Senior Advisor to Philips Healthcare, and a Courtesy Assistant Professor at the Department of Anesthesiology at the University of Florida.

Euliano holds a PhD in Signal Processing and Electrical Engineering, an MSEE in Electrical Engineering, and a BSE in Computer Science all from the University of Florida.

IMG_2742 (003).png

Kimberly Ramsey

Chief Financial Officer

A serial entrepreneur, with 30 years progressive corporate finance and operations experience, Ramsey has played a key role in raising over $100 million, including several successful IPOs. Most recently, she has been providing executive consulting services to medical device start-ups as founder and president of Bio/Med CXO. As co-founder and Chief Financial Officer for OBMedical Company, she played a key role in forwarding a ground-breaking wireless fetal/maternal monitor for use in labor and delivery departments, raising over $10M in private equity, leading to a successful acquisition by Philips Healthcare. Prior to that, she was key to successful mergers and IPOs in the biotech, med device and high-tech arenas.

 

Ramsey holds a BSAc from the Fisher School of Accounting at the University of Florida.

Kessler, Lou_5x7_3774-1.jpg

Louis G. Kessler, Ph.D.

Director of Intellectual Property

Dr. Kessler has over 30 years of industry experience and has served in a variety of entrepreneurial and advisory roles in the life science and high-tech fields.


He recently served as Senior Partner Intellectual Property at Arm Semiconductor. He was co-founder of ChaoLogix, Inc., a company that created and developed a new generation of secure-communication chips.  He served as its President and as a member of the Board until the company was acquired by Arm, Inc. in 2017. Before joining ChaoLogix, he was Vice President of Corporate Development at Ixion, a development-stage biotech company. Dr. Kessler was Director of Intellectual Properties and Technology Transfer at Univax (later Nabi) Biopharmaceuticals, a drug/vaccine development company. During his tenure at Univax the company went public, raising $44 million in its IPO.  He served as science adviser to a Washington, D.C. law firm and as a patent examiner in the U.S. Patent and Trademark Office. 


Dr. Kessler received a BS in Zoology from the University of South Florida and during that time served as a member of the U.S. Coast Guard Reserve.  He subsequently earned a Ph.D. in Molecular and Population Genetics from the University of Georgia.  He completed a postdoctoral fellowship in neurobiology at The University of Texas Southwestern Medical Center at Dallas. 

Chris Aytug -small-Director of Project Management -.jpg

Christine Aytug

Director of Business Development 

Ms. Aytug is a pharmaceutical and biotechnology professional with over 30 years' experience in a variety of commercial experiences at major and small companies.
She worked for 20 years at Glaxo Smith Kline in a variety of positions from bench research and oncology market research to oncology and respiratory product marketing and several sales positions. As the Director of Marketing, Sales and Contracts for Florida Biologix, a cGMP  biopharmaceutical manufacturing facility (for Phase I and II biologic therapeutics) affiliated with the University of Florida, she conducted all business development and proposal development activities and worked to establish a national presence for the organization.  

 

Aytug holds a BS in Zoology from Duke University and an MBA from the Fuqua School of Business at Duke.

Joshua Kelly Associate Product Manager_edited.jpg

Joshua kelly

Director of Operations

Josh Kelly started with the Company as an Associate Product Manager but was appointed Corporate Secretary in December 2021. He previously was a consultant with Asymetric Solutions, and a Deputy State Director - Wisconsin for In Field Strategies. He graduated with a degree in public relations from the University of Florida.

KimAnne Headshot.jpg

kim-anne dodd

Chair of Patient Advisory Committee

"If I don't do it, who will? If I don't lead by example, who will?"

Kim-Anne Dodd has always had a passion for helping others. She's served in the military as a Combat Medic, then continued her call to service with the Peace Corps, Red Cross and VA. Kim-Anne was raised in Oklahoma in foster care and joined the military at a young age. After being injured in Baghdad, she returned home and became a nurse working predominately for the VA in Nevada in the burn unit and hospice.

In 2017, when she saw the destruction of Hurricane Harvey, she signed up to volunteer with the Red Cross and was sent to Florida to help with Hurricane Irma. She had expected to stay for a standard two-week Red Cross deployment, but couldn't bring herself to leave so soon.​"I'm a soldier... I could not stop until the mission was over." Over the next three months, she volunteered all across the state of Florida, even completing forklift certification to help load supplies onto big rigs. After returning home, the Red Cross asked her to come back to Florida and help with long-term recovery. It was then that she decided to permanently move across the country to continue to serve the people in Florida. 

​As someone diagnosed with PTSD, Kim-Anne knows how desperately others need help to alleviate/nullify symptoms related to PTSD. ​Kim-Anne has been diagnosed with combat-related PTSD and is a survivor of a recent S.A. After losing a child and being present at the Christmas Paddock Mall shooting, both in 2023, she had no choice but to learn how to be a survivor of PTSD. She is the ideal person to help PTSD survivors learn how to thrive and utilize the newest devices and local resources. 

​​Kim-Anne knows that a support system is one of the most important things to have in your PTSD toolkit. She married her best friend, Jason, in December 2023. Jason and his family are a prime example of how a good support system can help a person in their PTSD journey. Her motto is and always has been, "Life is too short to do anything but smile. It is what you make it."

Sahil Raje Close Up.jpg

Sahil Raje

Business and Financial Analyst

Sahil Raje joined Evren Technologies as a business analyst in 2023. In his prior roles, Sahil participated as a graduate equity analyst of the Reese Fund portfolio at Indiana University. He` analyzed various securities in the financial industry and evaluated firm financials and growth factors to assess the viability of their business plans. During his internship, Sahil conducted data analysis for budgeting and financial planning purposes while supporting leadership in completing standard cost templates. At Florida State University, Sahil worked as a student equity researcher, collaborating with team members to trade securities in a $4.35M actively managed fund.

Sahil received a BS in Finance and Management Information Systems from Florida

State University and an MS in Finance from Indiana University.

bottom of page